4/30
09:00 am
fate
Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting
Low
Report
Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting
4/16
09:00 am
fate
Fate Therapeutics Announces Data Presentation of FT839 Next-Generation Off-The-Shelf CAR T-Cell Product Candidate for the Broad Treatment of Hematological Malignancies and Autoimmune Diseases Without the Need for Conditioning Chemotherapy at the AACR Annu
Low
Report
Fate Therapeutics Announces Data Presentation of FT839 Next-Generation Off-The-Shelf CAR T-Cell Product Candidate for the Broad Treatment of Hematological Malignancies and Autoimmune Diseases Without the Need for Conditioning Chemotherapy at the AACR Annu
4/16
01:28 am
fate
Fate Therapeutics Details Off-the-Shelf CAR T Progress in Lupus and Solid Tumors at Needham Conference [Yahoo! Finance]
Medium
Report
Fate Therapeutics Details Off-the-Shelf CAR T Progress in Lupus and Solid Tumors at Needham Conference [Yahoo! Finance]
4/9
09:00 am
fate
Fate Therapeutics to Participate in Upcoming Second Quarter 2026 Conferences
Medium
Report
Fate Therapeutics to Participate in Upcoming Second Quarter 2026 Conferences
4/2
04:05 pm
fate
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
3/27
09:15 am
fate
Scalable Biotech Manufacturing Unlocks a $14B Market
Medium
Report
Scalable Biotech Manufacturing Unlocks a $14B Market
3/18
11:30 am
fate
The $45 Billion Cell Therapy Boom Just Hit a Manufacturing Milestone Most Investors Haven’t Noticed
Medium
Report
The $45 Billion Cell Therapy Boom Just Hit a Manufacturing Milestone Most Investors Haven’t Noticed
3/16
04:20 am
fate
Fate Therapeutics Details FT819 CAR T Manufacturing and Phase II Lupus Trial Plans at Conference [Yahoo! Finance]
Medium
Report
Fate Therapeutics Details FT819 CAR T Manufacturing and Phase II Lupus Trial Plans at Conference [Yahoo! Finance]
3/4
04:05 pm
fate
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
3/3
04:14 pm
fate
Fate Therapeutics to Participate in Leerink Partners 2026 Global Healthcare Conference [Yahoo! Finance]
Medium
Report
Fate Therapeutics to Participate in Leerink Partners 2026 Global Healthcare Conference [Yahoo! Finance]
3/3
04:05 pm
fate
Fate Therapeutics to Participate in Leerink Partners 2026 Global Healthcare Conference
Medium
Report
Fate Therapeutics to Participate in Leerink Partners 2026 Global Healthcare Conference
3/3
10:49 am
fate
Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them [Globe and Mail, The (Toronto, Canada)]
Neutral
Report
Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them [Globe and Mail, The (Toronto, Canada)]
3/3
10:02 am
fate
Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them
Low
Report
Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them
2/26
03:33 pm
fate
Fate Therapeutics (FATE) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]
Low
Report
Fate Therapeutics (FATE) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]
2/26
09:35 am
fate
Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates [Yahoo! Finance]
High
Report
Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates [Yahoo! Finance]
2/26
09:00 am
fate
Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Medium
Report
Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
2/3
10:21 pm
fate
?????????????????????:2032???11750???????????? [CNET News]
Low
Report
?????????????????????:2032???11750???????????? [CNET News]
2/3
04:05 pm
fate
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)